| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |